Interleukin-17A mediates cardiomyocyte apoptosis through Stat3-iNOS pathway
- 1 November 2016
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1863 (11) , 2784-2794
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)Vascular Pharmacology, 2015
- Interleukin-17 and innate immunity in infections and chronic inflammationJournal of Autoimmunity, 2015
- Oxidative Myocardial Damage in Human Cocaine-Related CardiomyopathyEuropean Journal of Heart Failure, 2015
- IL-17A promotes ventricular remodeling after myocardial infarctionJournal of Molecular Medicine, 2014
- Interleukin-23 Deficiency Leads to Impaired Wound Healing and Adverse Prognosis After Myocardial InfarctionCirculation: Heart Failure, 2014
- Cell death in the myocardium: My heart won't go onIUBMB Life, 2013
- RETRACTED: Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injuryInternational Journal of Cardiology, 2013
- Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated CardiomyopathyCirculation Research, 2010
- The Second Window of Preconditioning (SWOP) Where Are We Now?Cardiovascular Drugs and Therapy, 2010
- The ubiquitous role of nitric oxide in cardioprotectionJournal of Molecular and Cellular Cardiology, 2006